Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-16269110 in obese subjects
NCT01041677Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Feb 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of usistapide in obesity, sponsored by Johnson & Johnson. Started Feb 2008; status: completed.
02
Drugs
usistapide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT01041677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01041677.